secwatch.observer — SEC 8-K summary
======================================

Issuer:     Vor Biopharma Inc. (VOR)
CIK:        0001817229
Form:       8-K
Filed at:   2022-12-07T23:59:59+00:00
Accession:  0001193125-22-300211
Event type: other_material
Sentiment:  neutral
Materiality: 0.80
Item codes: 1.01, 3.02, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Vor Biopharma prices $115.8M combined stock offering and private placement at $4.30/share
--------------------------------------------------------------------------------

- 15.3M shares sold in underwritten offering for gross $65.8M; 11.6M shares in private placement to RA Capital for $50M.
- Net proceeds from underwritten offering estimated at $61.4M after discounts and expenses; private placement net not disclosed.
- Proceeds to fund clinical pipeline development and working capital; closings expected December 9, 2022.
- Private placement shares are unregistered; company must file resale registration by Jan 8, 2023 or issue warrants by Dec 31, 2022.
- Underwriters: Evercore, Stifel, Oppenheimer; RA Capital is company's largest stockholder.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1817229/000119312522300211/0001193125-22-300211-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1817229/000119312522300211/d411199d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-22-300211

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer